Company intelligence / Profile preview

EvidNet

Seoul, Seoul, South Korea

Ownership: Private
Employees: ~75
Development stage: Other

Overview

EvidNet is a South Korean healthcare data and real-world evidence company that builds and operates a federated medical data platform for hospitals, researchers, and life sciences customers. The company standardizes hospital data using common data models such as OMOP-CDM and provides tools for multicenter research, retrospective studies, trial feasibility, pharmacovigilance, and patient-facing health data services. Its commercial product suite includes EVIX-ONE, EVIX-MART, EVIX-INSIGHT, EVIX-INSIGHT PRO, EVIX-EXPLO, EVIX-FIND, EVIX-RESEARCH, EVIX-PV/PMS, and EVIX-HEALTH. EvidNet appears to be a platform and services business rather than a therapeutic drug developer, with revenue generated from data-network access, analytics, and research support for healthcare and life sciences users.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Data4LifeClinerion

Beyond the preview

Go deeper on EvidNet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EvidNet.

Explore the full profile